company-logo

Lisata Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and CLBS201, a CD34+ cell therapy for the treatment of pre-dialysis patients with chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Lisata Therapeutics Dividend Announcement

Lisata Therapeutics announced a annually dividend of $0.00 per ordinary share which will be made payable on . Ex dividend date: 2013-10-28
Lisata Therapeutics's trailing twelve-month (TTM) dividend yield is -%

Lisata Therapeutics Dividend History

Ex-Div dateDividend amountDividend typePay date
2013-10-28$0.00annually
2011-04-04$0.00annually

Lisata Therapeutics Dividend per year

Lisata Therapeutics Dividend Yield

Lisata Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Lisata Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Lisata Therapeutics Financial Ratios

P/E ratio-1.06
PEG ratio-0.09
P/B ratio0.65
ROE-50.87%
Payout ratio0.00%
Current ratio8.03
Quick ratio8.03
Cash Ratio4.16

Lisata Therapeutics Dividend FAQ

Does Lisata Therapeutics stock pay dividends?
Lisata Therapeutics does not currently pay dividends to its shareholders.
Has Lisata Therapeutics ever paid a dividend?
No, Lisata Therapeutics has no a history of paying dividends to its shareholders. Lisata Therapeutics is not known for its dividend payments.
Why doesn't Lisata Therapeutics pay dividends?
There are several potential reasons why Lisata Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Lisata Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Lisata Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Lisata Therapeutics a dividend aristocrat?
Lisata Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Lisata Therapeutics a dividend king?
Lisata Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Lisata Therapeutics a dividend stock?
No, Lisata Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Lisata Therapeutics stocks?
To buy Lisata Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Lisata Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.